Additionally, the AUC of the combination of anti-TIF1γ-IgA with anti-TIF1γ-IgG for the patients with early LC was 0.734, with 38.31% sensitivity at 92.34% specificity (Table 3, Table 4, Figure 3). Here, CD79A is linked to laryngotracheoesophageal cleft.